Evidence map›Paper›PMID 31872528›Full record

ArticleActa physiologica (Oxford, England)2020

In vivo hyperglycaemia exposure elicits distinct period-dependent effects on human pancreatic progenitor differentiation, conveyed by oxidative stress.

Thomas A Legøy, Luiza Ghila, Heidrun Vethe, Shadab Abadpour, Andreas F Mathisen, Joao A Paulo, Hanne Scholz, Helge Raeder, Simona Chera

Open access · bronzeAbstract read
In one paragraph

Article in Acta physiologica (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
  9. Article
  10. Frontiers in cell and developmental biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Thomas A LegøyDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Luiza GhilaDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0001-7173-6312
Heidrun VetheDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Shadab AbadpourHybrid Technology Hub-Centre of Excellence, Faculty of Medicine, University of Oslo, Oslo, Norway.
Andreas F MathisenDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, MA, USA.
Hanne ScholzHybrid Technology Hub-Centre of Excellence, Faculty of Medicine, University of Oslo, Oslo, Norway.
Helge RaederDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Simona CheraDepartment of Clinical Science, University of Bergen, Bergen, Norway.ORCID 0000-0001-6310-3486
University of Bergen · NOOslo University Hospital · NOHarvard University · USHaukeland University Hospital · NO

Funding

New Sample Multiplexing Technologies to Identify Chemical Probes and Illuminate Ubiquitin BiologyR01GM067945 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2003 to 2024
$10.5M
Advancing Multiplexed Isobaric Tag-based Strategies for Proteome ProfilingR01GM132129 · NIGMS · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2019 to 2023
$1.7M
Resolving the role of nicotine-mediated phosphorylation on pancreatic fibrosisK01DK098285 · NIDDK · HARVARD MEDICAL SCHOOL · PI PAULO, JOAO A · 2013 to 2017
$638k
NIDDK NIH HHS K01 DK098285NIGMS NIH HHS R01 GM132129
6 · The paper itself

Abstract

aimThe loss of insulin-secreting β-cells, ultimately characterizing most diabetes forms, demands the development of cell replacement therapies. The common endpoint for all ex vivo strategies is transplantation into diabetic patients. However, the effects of hyperglycaemia environment on the transplanted cells were not yet properly assessed. Thus, the main goal of this study was to characterize global effect of brief and prolonged in vivo hyperglycaemia exposure on the cell fate acquisition and maintenance of transplanted human pancreatic progenitors.

methodsTo rigorously study the effect of hyperglycaemia, in vitro differentiated human-induced pluripotent stem cells (hiPSC)-derived pancreatic progenitors were xenotransplanted in normoglycaemic and diabetic NSG rat insulin promoter (RIP)-diphtheria toxin receptor (DTR) mice. The transplants were retrieved after 1-week or 1-month exposure to overt hyperglycaemia and analysed by large-scale microscopy or global proteomics. For this study we pioneer the use of the NSG RIP-DTR system in the transplantation of hiPSC, making use of its highly reproducible specific and absolute β-cell ablation property in the absence of inflammation or other organ toxicity.

resultsHere we show for the first time that besides the presence of an induced oxidative stress signature, the cell fate and proteome landscape response to hyperglycaemia was different, involving largely different mechanisms, according to the period spent in the hyperglycaemic environment. Surprisingly, brief hyperglycaemia exposure increased the bihormonal cell number by impeding the activity of specific islet lineage determinants. Moreover, it activated antioxidant and inflammation protection mechanisms signatures in the transplanted cells. In contrast, the prolonged exposure was characterized by decreased numbers of hormone + cells, low/absent detoxification signature, augmented production of oxygen reactive species and increased apoptosis.

conclusionHyperglycaemia exposure induced distinct, period-dependent, negative effects on xenotransplanted human pancreatic progenitor, affecting their energy homeostasis, cell fate acquisition and survival.

Indexed as

AdultAnimalsBlood GlucoseCell DifferentiationDiabetes Mellitus, ExperimentalHeparin-binding EGF-like Growth FactorHumansHyperglycemiaInduced Pluripotent Stem CellsInsulinInsulin-Secreting CellsIslets of LangerhansIslets of Langerhans TransplantationMaleMiceMice, TransgenicBlood GlucoseHeparin-binding EGF-like Growth FactorInsulindifferentiationendocrine progenitorshuman iPSCshyperglycaemiaRIP-DTRxenotransplantation

Identifiers

PMID31872528
PMCPMC7078042
OpenAlexW2998620454

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.